StockData
Globus Medical Inc logo

Globus Medical Inc (GMED) shareholders

GMEDNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3044% below fair value
$70.53+0.54 (+0.77%)

Close on Nov 18, 2026Market cap $9.47BP/E 18.0Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
88.9%
119M of 134M shares
Institutional holders
597
83 new, 86 sold out
Net institutional buying
18M
In Q2 2026
Insider trades, 12 months
0 buys · 13 sales
Net sold $16.02M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Sonali Paul
Joint filing with David C. Paul (15.76%)
22,087,89716.24%13G (passive) amendmentDec 31, 2023
BlackRock, Inc.10,704,2838.00%13G (passive) amendmentSep 30, 2026
Janus Henderson Group PLC7,029,2946.10%13G (passive) amendmentMar 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of GMEDValueChange% of portfolio
BlackRock, Inc.10,806,7248.05%$853.84M+309,3100.01%
Jupiter Topco LLC8,200,4236.11%$647.93MNew0.26%
Vanguard Capital Management LLC5,107,5323.80%$403.55M+74,8000.01%
Vanguard Portfolio Management LLC4,994,3853.72%$394.61M+114,9260.02%
Invesco Ltd.4,309,7713.21%$340.52M−6,8830.03%
Kayne Anderson Rudnick Investment Management LLC4,279,7303.19%$338.14MNew1.05%
State Street Corp3,714,0292.77%$293.54M+123,6570.01%
Sculptor Capital LP3,000,0002.23%$237.03M−58,0001.93%
JPMorgan Chase & Co2,743,8502.04%$230.76M+148,5420.01%
Bank Of Montreal /Can/2,425,4911.81%$191.64M+118,3100.06%
Alliancebernstein L.P.2,380,3441.77%$205.09M+629,5120.07%
Dimensional Fund Advisors LP2,369,3101.76%$187.25M+599,4130.03%
Geode Capital Management, LLC2,153,0141.60%$170.15M+40,8900.01%
Goldman Sachs Group Inc1,781,6081.33%$140.76M+649,4460.01%
Arrowstreet Capital, Limited Partnership1,716,6211.28%$135.63M+803,7160.06%
Boston Trust Walden Corp1,573,3611.17%$124.31M+318,4510.95%
Allspring Global Investments Holdings, LLC1,571,6811.17%$119.38M+1,143,6410.18%
Boston Partners1,554,9901.16%$122.85MNew0.11%
GW&K Investment Management, LLC1,453,2061.08%$114.82M−41,5170.90%
Geneva Capital Management LLC1,417,0671.06%$111.96M−343,9042.57%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026597119M88.9%83 / 252181 / 8629M12M
Q1 2026607110M81.6%108 / 231183 / 5322M14M
Q4 2025563112M83.6%132 / 150221 / 5020M22M
Q3 2025490120M89.1%80 / 173177 / 6422M17M
Q2 2025481115M85.8%67 / 195150 / 9419M13M
Q1 2025513110M81.9%92 / 204143 / 6814M12M
Q4 2024500109M81.1%104 / 168154 / 4314M15M
Q3 2024449111M82.5%54 / 147175 / 5216M12M
Q2 2024450117M87.0%69 / 136167 / 5512M12M
Q1 2024438117M87.1%72 / 143150 / 4216M10M
Q4 2023408111M82.5%52 / 134161 / 6517M16M
Q3 2023431109M81.5%92 / 21074 / 4136M8M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

489 funds held GMED in Q2 2026, 41% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of GMEDValue% of fundAs of
iShares Core S&P Mid-Cap ETF3,877,9352.89%$306.40M0.25%Jun 30, 2026
Vanguard Total Stock Market Index Fund3,595,5642.68%$284.09M0.01%Jun 30, 2026
Vanguard Small-Cap Index Fund2,597,8151.93%$205.25M0.11%Jun 30, 2026
Janus Henderson Enterprise Fund2,207,1411.64%$174.39M0.78%Jun 30, 2026
Vanguard Small-Cap Growth Index Fund1,496,5001.11%$118.24M0.25%Jun 30, 2026
JPMorgan Mid Cap Value Fund1,475,9781.10%$116.62M1.04%Jun 30, 2026
Vanguard Extended Market Index Fund1,299,4840.97%$102.67M0.11%Jun 30, 2026
Allspring Special Mid Cap Value Fund1,234,4950.92%$97.54M0.72%Jun 30, 2026
Janus Henderson Triton Fund1,111,3470.83%$87.81M1.48%Jun 30, 2026
Disciplined Value Mid Cap Fund1,030,7250.77%$81.44M0.35%Jun 30, 2026
Invesco Small Cap Value Fund1,012,3590.75%$79.76M0.72%Jul 31, 2026
Invesco Value Opportunities Fund825,0320.61%$65.00M0.71%Jul 31, 2026
Janus Henderson Global Life Sciences Fund744,4210.55%$58.82M1.01%Jun 30, 2026
Fullerthaler Behavioral Small-Cap Growth738,6000.55%$58.36M0.94%Jun 30, 2026
iShares S&P Mid-Cap 400 Growth ETF678,0280.51%$53.57M0.47%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
David C. PaulExecutive Chairman, Director, 10% owner23,087,80817.20%Jan 23, 2026
Keith W. PfeilPresident, CEO, Director5,8330.00%Jan 23, 2026
Daniel T. ScavillaPresident, CEO, Director0–Mar 28, 2025
Kelly HullerEVP, GC, Corporate Secretary0–Feb 27, 2026
Kyle KlineSenior Vice President, CFO0–Jan 23, 2026
James R. TobinDirector0–Nov 12, 2026
Ann D. RhoadsDirector35,3840.03%Nov 5, 2026
Stephen T. ZarrilliDirector25,0000.02%Aug 19, 2026
David D. DavidarDirector673,6420.50%Jul 28, 2026
Robert Andrew DouglasDirector2,0050.00%Jan 23, 2026
Leslie V. NorwalkDirector10,4190.01%Jan 23, 2026
Dan WoltermanDirector24,0250.02%Jan 23, 2026
John A. DeFordDirector15,5780.01%Jan 23, 2026
Dan LemaitreDirector1,0970.00%Jan 23, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
James R. Tobin
Director
Nov 10, 2026Sale−4,004$75.68$303.04K0
James R. Tobin
Director
Nov 10, 2026Sale−37,662$75.10$2.83M4,004
James R. Tobin
Director
Nov 10, 2026Option exercise+5,208$43.58$226.96K41,666
James R. Tobin
Director
Nov 10, 2026Option exercise+21,458$53.27$1.14M36,458
James R. Tobin
Director
Nov 10, 2026Option exercise+15,000$65.05$975.75K15,000
Ann D. Rhoads
Director
Nov 4, 2026Sale(10b5-1 plan)−5,000$85.00$425.00K35,384
James R. Tobin
Director
Sep 15, 2026Sale−30,000$74.58$2.24M0
James R. Tobin
Director
Sep 15, 2026Option exercise+15,000$63.68$955.20K30,000
James R. Tobin
Director
Sep 15, 2026Option exercise+15,000$53.75$806.25K15,000
Stephen T. Zarrilli
Director
Aug 18, 2026Option exercise+25,000$53.27$1.33M25,000
Stephen T. Zarrilli
Director
Aug 18, 2026Sale−25,000$87.04$2.18M0
David D. Davidar
Director
Jul 27, 2026Gift−2,500––507,675
David D. Davidar
Director
Jun 5, 2026Sale−25,000$80.76$2.02M510,175
David D. Davidar
Director
Jun 5, 2026Option exercise+25,000$26.27$656.75K535,175
Ann D. Rhoads
Director
Jun 4, 2026Option exercise+25,000$26.27$656.75K40,384
Kelly Huller
EVP, GC, Corporate Secretary
Feb 25, 2026Sale(10b5-1 plan)−20,000$94.50$1.89M0
Kelly Huller
EVP, GC, Corporate Secretary
Feb 25, 2026Option exercise+20,000$43.58$871.60K20,000
Kelly Huller
EVP, GC, Corporate Secretary
Feb 12, 2026Sale(10b5-1 plan)−10,000$87.67$876.70K0
Kelly Huller
EVP, GC, Corporate Secretary
Feb 12, 2026Option exercise+10,000$45.64$456.40K10,000
Leslie V. Norwalk
Director
Jan 8, 2026Sale(10b5-1 plan)−2,000$101.10$202.20K10,419
Kyle Kline
Senior Vice President, CFO
Jan 8, 2026Sale(10b5-1 plan)−3,594$101.10$363.35K0
Kyle Kline
Senior Vice President, CFO
Jan 8, 2026Option exercise+3,594$51.87$186.42K3,594
Leslie V. Norwalk
Director
Dec 12, 2025Sale(10b5-1 plan)−4,000$88.85$355.40K12,419
David C. Paul
Executive Chairman, Director, 10% owner
Dec 8, 2025Option exercise+34,375$25.52$877.25K60,417
Kyle Kline
Senior Vice President, CFO
Dec 1, 2025Sale(10b5-1 plan)−18,542$90.00$1.67M0
Kyle Kline
Senior Vice President, CFO
Dec 1, 2025Option exercise+4,896$63.68$311.78K18,542
Kyle Kline
Senior Vice President, CFO
Dec 1, 2025Option exercise+5,000$64.44$322.20K13,646
Kyle Kline
Senior Vice President, CFO
Dec 1, 2025Option exercise+5,000$56.43$282.15K8,646
Kyle Kline
Senior Vice President, CFO
Dec 1, 2025Option exercise+3,646$53.14$193.75K3,646
Kelly Huller
SVP, GC, Corporate Secretary
Nov 25, 2025Option exercise+7,500$25.96$194.70K7,500
Kelly Huller
SVP, GC, Corporate Secretary
Nov 25, 2025Sale(10b5-1 plan)−7,500$90.00$675.00K0
David D. Davidar
Director
Nov 12, 2025Sale−25,000$86.00$2.15M516,275
David D. Davidar
Director
Nov 12, 2025Option exercise+25,000$25.52$638.00K541,275
Stephen T. Zarrilli
Director
Nov 11, 2025Sale−25,000$84.29$2.11M0
Stephen T. Zarrilli
Director
Nov 11, 2025Option exercise+25,000$44.14$1.10M25,000
Ann D. Rhoads
Director
Nov 10, 2025Sale(10b5-1 plan)−2,000$85.00$170.00K15,384
Ann D. Rhoads
Director
Nov 7, 2025Sale(10b5-1 plan)−8,000$81.00$648.00K17,384
Ann D. Rhoads
Director
Sep 15, 2025Sale(10b5-1 plan)−10,000$58.46$584.60K25,384
Ann D. Rhoads
Director
Feb 28, 2025Sale(10b5-1 plan)−7,500$78.68$590.10K35,384
Keith W. Pfeil
COO, CFO
Jan 10, 2025Option exercise+5,833$49.65$289.61K5,833
Keith W. Pfeil
COO, CFO
Jan 10, 2025Sale(10b5-1 plan)−12,501$88.17$1.10M1,666
Keith W. Pfeil
COO, CFO
Jan 10, 2025Sale(10b5-1 plan)−1,666$89.17$148.56K0
Keith W. Pfeil
COO, CFO
Jan 10, 2025Option exercise+8,334$53.27$443.95K14,167
David D. Davidar
Director
Jan 2, 2025Gift−6,100––510,175
Kelly Huller
SVP, GC, Corporate Secretary
Dec 2, 2024Option exercise+2,500$24.21$60.53K2,500
Kelly Huller
SVP, GC, Corporate Secretary
Dec 2, 2024Sale(10b5-1 plan)−2,500$87.00$217.50K0
David D. Davidar
Director
Nov 22, 2024Sale(10b5-1 plan)−6,766$85.00$575.11K516,275
David D. Davidar
Director
Nov 22, 2024Sale(10b5-1 plan)−6,746$85.00$573.41K165,967
Dan Lemaitre
Director
Nov 22, 2024Option exercise+1,097$65.05$71.36K1,097
Dan Lemaitre
Director
Nov 22, 2024Sale−1,097$85.02$93.27K0
David D. Davidar
Director
Nov 21, 2024Sale(10b5-1 plan)−13,234$85.00$1.12M523,041
David D. Davidar
Director
Nov 21, 2024Sale(10b5-1 plan)−13,254$85.00$1.13M172,713
Dan Lemaitre
Director
Nov 21, 2024Sale−13,278$85.00$1.13M0
Dan Lemaitre
Director
Nov 21, 2024Option exercise+13,278$65.05$863.73K13,278
Daniel T. Scavilla
President, CEO, Director
Nov 21, 2024Sale(10b5-1 plan)−130,000$85.00$11.05M0
Daniel T. Scavilla
President, CEO, Director
Nov 21, 2024Option exercise+80,000$43.58$3.49M130,000
Daniel T. Scavilla
President, CEO, Director
Nov 21, 2024Option exercise+50,000$43.77$2.19M50,000
David C. Paul
Executive Chairman, Director, 10% owner
Nov 15, 2024Option exercise+26,042$24.10$627.61K26,042
Daniel T. Scavilla
President, CEO, Director
Nov 6, 2024Option exercise+30,000$26.27$788.10K30,000
Daniel T. Scavilla
President, CEO, Director
Nov 6, 2024Option exercise+30,000$43.77$1.31M60,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
8.57%
9M shares short
Days to cover
8.1
At 1M shares a day
Change since last report
+15.5%
From 8M shares
Short volume, 20 days
53.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Globus Medical's stock actually held short. Settlement fails (shares not delivered on time) peaked at 66,330 shares on Sep 10, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
James R. Tobin
Director
Nov 10, 202641,666$3.13MNov 10, 2026Cashless Stock Option Exercise
Ann D. Rhoads
Director
Nov 4, 20265,000$425.00KNov 4, 2026Stock Option Exercise
James R. Tobin
Director
Sep 15, 202630,000$2.24MSep 15, 2026Cashless Option Exercise
Stephen T. Zarrilli
Director
Aug 18, 202625,000$2.18MAug 18, 2026Cashless Option Exercise
David D. Davidar
Director
Jun 5, 202625,000$2.03MJun 5, 2026Cashless Option Exercise
John A. DeFord
Former Director
Apr 14, 202630,000$2.79MApr 14, 2026Cashless Stock Option
Kelly Huller
Officer
Feb 25, 202620,000$1.89MFeb 25, 2026Cashless Stock Option Exercise
Kelly Huller
Officer
Feb 12, 202610,000$876.00KFeb 12, 2026Cashless Option Exercise
Kyle Kline
Officer
Jan 8, 20263,594$363.17KJan 8, 2026CASHLESS OPTION EXERCISE
Leslie V. Norwalk
Director
Jan 8, 20262,000$202.00KJan 8, 2026RSU Vesting
Leslie V. Norwalk
Director
Dec 12, 20254,000$355.00KDec 12, 2025RSU Vesting
Kyle Kline
Officer
Dec 1, 202518,542$1.67MDec 1, 2025Cashless Stock Option Exercise
Kelly Huller
Officer
Nov 25, 20257,500$675.00KNov 25, 2025Cashless Stock Option Exercise
Stephen T. Zarrilli
Director
Nov 12, 202525,000$2.11MNov 11, 2025Cashless Stock Option Exercise
David D. Davidar
Director
Nov 12, 202525,000$2.15MNov 12, 2025Cashless Option Exercise

Congress trades

12 trades in Globus Medical reported by 5 members of the House

MemberTypeTradedAmountFiled
Gilbert Cisneros
CA31
BoughtSep 3, 2026$1K–15KOct 12, 2026
Gilbert Cisneros
CA31
BoughtAug 19, 2026$15K–50KSep 10, 2026
Gilbert Cisneros
CA31
BoughtMar 3, 2026$1K–15KApr 7, 2026
Lisa McClain
MI09 · spouse
SoldJul 10, 2025$1K–15KAug 13, 2025
Lisa McClain
MI09 · spouse
Sold (part)Jun 24, 2025$1K–15KAug 13, 2025
50 days late
Lisa McClain
MI09 · spouse
BoughtJun 17, 2025$1K–15KAug 13, 2025
57 days late
Josh Gottheimer
NJ05 · joint account
Sold (part)Apr 9, 2025$1K–15KMay 14, 2025
Josh Gottheimer
NJ05 · joint account
BoughtApr 3, 2023$1K–15KMay 19, 2023
46 days late
Daniel Goldman
NY10
SoldMar 6, 2023$15K–50KApr 17, 2023
Josh Gottheimer
NJ05 · joint account
Sold (part)Feb 8, 2023$1K–15KMar 17, 2023
Josh Gottheimer
NJ05 · joint account
Sold (part)Jan 11, 2023$1K–15KFeb 17, 2023
Lois Frankel
FL22
BoughtOct 6, 2016$1K–15KOct 21, 2016

See a number that looks wrong?